Meyer Handelman Co. Increases Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
Meyer Handelman Co. lifted its stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 11.4% during the 3rd quarter, according to the company in its most recent filing with the SEC. The fund owned 4,235 shares of the biopharmaceutical company’s stock after acquiring an additional 435 shares during the quarter. Meyer Handelman Co.’s holdings […]